Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Shenguan Holdings (Group) Limited ( (HK:0829) ) is now available.
Shenguan Holdings reported largely flat revenue of RMB1.02 billion for 2025, but swung from a profit to a net loss attributable to shareholders of RMB69.8 million as gross profit fell and cost of sales rose. The company also recorded net cash outflows from operating activities, a modest decline in total assets, and lengthening inventory and trade cycle days, while the board decided not to declare a final or special dividend for the year.
The results suggest mounting margin pressure and operational headwinds, as weaker profitability, rising inventories and extended payables and receivables days point to softer demand and tighter working capital conditions. These dynamics may weigh on Shenguan’s financial flexibility and could prompt closer scrutiny from investors and creditors, particularly given the reversal from earnings to losses despite stable top-line performance.
The most recent analyst rating on (HK:0829) stock is a Hold with a HK$0.24 price target. To see the full list of analyst forecasts on Shenguan Holdings (Group) Limited stock, see the HK:0829 Stock Forecast page.
More about Shenguan Holdings (Group) Limited
Shenguan Holdings (Group) Limited is a Cayman Islands-incorporated company listed in Hong Kong that operates in the collagen and related products industry. The group focuses on manufacturing and selling collagen-based casings and related materials, serving food-processing customers and industrial users primarily in mainland China and export markets.
Average Trading Volume: 635,263
Technical Sentiment Signal: Sell
Current Market Cap: HK$775.3M
Find detailed analytics on 0829 stock on TipRanks’ Stock Analysis page.